Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Lactose (India)BOM:524202 -4.95%76 Days Payable is 100.48 as of Jun. 2026, which is 7% above its 10-year median of 94.17. GuruFocus rates BOM:524202 with a GF Score™ of 76/100 and a GF Value™ of ₹164.26 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 926 Drug Manufacturers companies, Lactose (India) ranks worse than 66.74% on this metric.
The historical rank and industry rank for Lactose (India)'s Days Payable or its related term are showing as below:
BOM:524202'
s Days Payable Range Over the Past 10 Years
Min: 44.78 Med: 94.17 Max: 221.34
Current: 59.82
During the past 13 years, Lactose (India)'s highest Days Payable was 221.34. The lowest was 44.78. And the median was 94.17.
BOM:524202's Days Payable is ranked worse than 66.74% of 926
companies
in the Drug Manufacturers industry
Industry Median: 88.745
vs BOM:524202: 59.82
Lactose (India)'s Days Payable
increased
from Jun. 2025 (32.97) to Jun. 2026 (100.48).
It may suggest that Lactose (India)delayed paying its suppliers.
The historical data trend for Lactose (India)'s Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Lactose (India)'s Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lactose (India) Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Lactose (India)'s Days Payable distribution charts can be found below:
* The bar in red indicates where Lactose (India)'s Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Lactose (India)'s Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lactose (India) (BOM:524202) has a Days Payable of 100.48 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Lactose (India) and its competitors. This is near median its historical median of 94.17. Over the past decade, Lactose (India)'s Days Payable has ranged from 44.78 to 221.34. According to the industry distribution chart, Lactose (India) ranks #618 out of 926 companies in the Drug Manufacturers industry, placing it in the top 66.7%.
Is Lactose (India)'s Days Payable too high?
Lactose (India)'s current Days Payable of 100.48 is near median its 10-year median of 94.17. Over the past 10 years, this metric has ranged from a low of 44.78 to a high of 221.34. The Drug Manufacturers industry median Days Payable is 88.75. Lactose (India)'s value of 100.48 is 13.2% above this industry median. Based on the distribution chart, Lactose (India) ranks #618 out of 926 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Lactose (India) has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Lactose (India)'s Days Payable compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Lactose (India) ranks #618 out of 926 companies for Days Payable. This places Lactose (India) in the lower half of its industry. The industry median Days Payable is 88.75. Lactose (India)'s value of 100.48 is 13.2% above this benchmark. Historically, Lactose (India)'s own Days Payable has ranged from 44.78 to 221.34 over the past decade. While the company's 10-year median is 94.17 vs. the industry median of 88.75, Lactose (India) has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 88.75, based on 926 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Lactose (India)'s current Days Payable of 100.48 is 13.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Lactose (India) and its competitors. For the Drug Manufacturers industry, the median Days Payable is 88.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lactose (India)'s current Days Payable is 100.48, which is near median its own 10-year median of 94.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lactose (India) stock overvalued right now?
Based on GuruFocus' analysis, Lactose (India) (BOM:524202) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹164.26, compared to a current price of ₹100.75 — trading 38.7% below its estimated fair value. The current Days Payable is 100.48, which is near median its 10-year median of 94.17 and 13.2% above the Drug Manufacturers industry median of 88.75. Lactose (India)'s overall GF Score™ is 76/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Lactose (India) (BOM:524202), the current Days Payable is 100.48 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Lactose (India) (BOM:524202) Overvalued in 2026?
Based on GuruFocus' analysis, Lactose (India) stock appears to be undervalued.
The current stock price of ₹100.75 is trading 38.7% below its estimated GF Value™ of ₹164.26.
GuruFocus considers Lactose (India) to be Significantly Undervalued.
Key valuation signals for BOM:524202:
Days Payable: 100.48 (near median its 10-year median of 94.17)
GF Value™: ₹164.26 vs. price of ₹100.75 (38.7% below fair value)
Industry Position: 13.2% above the Drug Manufacturers median (#618 of 926)
No single metric tells the full story. See the BOM:524202 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Lactose (India) Ltd is an India based pharmaceutical company. It is principally engaged in the manufacturing and trading of pharmaceutical products. The company offers pharmaceutical products like Lactose monohydrate, Dry granulated, Film and lacquer coated tablets, Disaccharide lactulose, and Liquid dose form products. Manufacturing of lactose monohydrate and other pharmaceutical products generates revenue for the company. The company sells its products in India and also exports its products internationally.
76GF Score
Get the complete analysis for BOM:524202
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524202 has been successfully added to your 
